Technical Documentation & CE Marking
Comprehensive technical file compilation, GSPR demonstration, and conformity assessment support — from initial documentation strategy through notified body submission and CE marking for EU MDR, IVDR, and FDA pathways.
Overview
Technical documentation is the evidentiary foundation upon which medical device market access depends. Under EU MDR 2017/745 and IVDR 2017/746, manufacturers must compile and maintain a structured technical file that demonstrates compliance with all applicable General Safety and Performance Requirements (GSPRs), incorporating design and manufacturing information, risk management outputs, clinical evaluation, biocompatibility data, and post-market surveillance plans. The technical documentation requirements under the MDR represent a substantial increase in depth and specificity compared to the former Medical Devices Directive (MDD 93/42/EEC), and notified bodies are applying significantly more scrutiny during conformity assessments.
Swiss MPC has guided manufacturers through hundreds of successful CE marking submissions across all device risk classes, from Class I self-declared devices to Class III implantable technologies requiring full notified body review. Our consultants bring direct experience with the documentation expectations of major European notified bodies including BSI, TUV SUD, TUV Rheinland, DEKRA, and SGS. We understand not only what information must be present in a technical file, but how it must be structured, cross-referenced, and presented to facilitate efficient notified body review and minimize requests for supplementary information.
Beyond European market access, we support manufacturers pursuing FDA clearance and approval through 510(k) premarket notification, De Novo classification, and Premarket Approval (PMA) pathways. Our team prepares comprehensive submission packages that address FDA-specific requirements including predicate device comparisons, performance testing summaries, software documentation (where applicable), and biocompatibility evaluations following FDA-recognized consensus standards. We coordinate parallel EU and FDA documentation strategies to maximize content reuse and minimize duplicative effort across regulatory jurisdictions.
Our technical documentation services extend throughout the entire product lifecycle. We establish and maintain Design History Files (DHFs) that capture the complete design and development record, manage design change documentation and impact assessments, and ensure that post-market surveillance data feeds back into technical file updates as required by Article 83 of the MDR. For manufacturers transitioning from MDD to MDR, we conduct comprehensive gap analyses of existing technical files and develop targeted remediation plans that address new MDR requirements while preserving and leveraging existing compliant documentation.
Technical Documentation Challenges Manufacturers Face
MDD to MDR Transition Gaps
Technical files created under the MDD often lack the depth required by the MDR, particularly in areas such as clinical evaluation per MEDDEV 2.7/1 Rev 4, post-market surveillance planning, benefit-risk analysis, and GSPR mapping. Manufacturers frequently underestimate the scope of remediation required, discovering during notified body review that their existing documentation does not meet the elevated MDR standard. This is compounded by the fact that many notified bodies now expect MDR-level documentation even for devices still covered by MDD certificates during the transition period.
GSPR Compliance Demonstration
The General Safety and Performance Requirements (Annex I of EU MDR) comprise 23 general requirements and additional specific requirements depending on device type. Demonstrating compliance requires systematic mapping of each applicable GSPR to specific evidence — design verification results, testing reports, clinical data, risk management outputs, and standards compliance. Manufacturers often struggle to establish clear traceability between GSPRs and supporting evidence, leading to notified body findings and extended review cycles.
Design History File Completeness
The DHF must capture the entire design and development process, including user needs, design inputs and outputs, verification and validation records, risk management activities, and design transfer documentation. For devices developed over many years or through acquisitions, the historical design record may be fragmented, incomplete, or not structured according to current regulatory expectations. Reconstructing or supplementing these records while maintaining document integrity is a common and resource-intensive challenge.
Multi-Jurisdiction Documentation Strategy
Manufacturers targeting both EU and US markets — and increasingly markets in Asia, the Middle East, and Latin America — must prepare documentation that satisfies multiple regulatory frameworks simultaneously. While there is significant content overlap between EU technical files and FDA submissions, differences in format, terminology, clinical evidence expectations, and testing standards require careful coordination to avoid duplicative effort while ensuring each submission meets its specific regulatory requirements.
Notified Body Capacity and Review Timelines
The reduced number of MDR-designated notified bodies has created significant capacity constraints, leading to extended review timelines and increasingly rigorous documentation scrutiny. Notified bodies are issuing more supplementary information requests and conducting more thorough technical documentation assessments. Manufacturers must submit technically impeccable documentation to avoid costly delays and maintain their market access timelines.
Our Technical Documentation Approach
Documentation Gap Analysis and Strategy
We conduct a systematic review of your existing technical documentation against the full requirements of EU MDR Annex II and Annex III, FDA submission requirements (as applicable), and the specific expectations of your target notified body. The gap analysis produces a detailed findings report with prioritized remediation actions, resource estimates, and a documentation roadmap aligned with your market access timeline.
GSPR Mapping and Evidence Planning
We develop a comprehensive GSPR compliance matrix that maps each applicable General Safety and Performance Requirement to specific evidence sources — standards, testing reports, clinical data, risk management outputs, and design records. Where evidence gaps exist, we define the testing, analysis, or documentation activities needed to demonstrate compliance and integrate these into the project plan.
Technical File Compilation
Our regulatory writers compile the complete technical documentation set, including device description and specification, design and manufacturing information, risk management file summary, clinical evaluation report, biocompatibility assessment, sterilization validation summary, packaging validation, software documentation (IEC 62304 deliverables where applicable), and labeling assessment. Every document is cross-referenced and structured for efficient notified body review.
Risk Management Integration
We ensure your risk management file — developed in accordance with ISO 14971:2019 — is fully integrated with the technical documentation. This includes verifying that the risk management process covers all identified hazards, that risk control measures are traceable to design outputs and verification records, and that the overall residual risk is evaluated against the clinical benefit as required by EU MDR Annex I, Chapter I, Section 8.
Notified Body Submission and Support
We prepare and organize the complete submission package according to your notified body's preferred format and submission portal requirements. During the conformity assessment process, we manage responses to supplementary information requests, coordinate with your technical teams to provide additional evidence or clarification, and track the review through to certificate issuance and Declaration of Conformity execution.
Post-Certification Maintenance
Technical documentation is a living system that must be updated throughout the device lifecycle. We establish documentation maintenance procedures, manage design change impact assessments, integrate post-market surveillance and vigilance data into technical file updates, and prepare for periodic notified body surveillance audits. Our ongoing support ensures your technical documentation remains compliant as regulations, standards, and clinical evidence evolve.
Technical Documentation Deliverables
- Gap analysis report with prioritized remediation roadmap
- GSPR compliance matrix with full evidence mapping (EU MDR Annex I)
- Complete technical file structured per EU MDR Annex II and Annex III
- Device description and specification document
- Design and manufacturing information (DMI) package
- Risk management file summary per ISO 14971:2019
- Clinical evaluation report per MEDDEV 2.7/1 Rev 4 and MDCG guidance
- Biocompatibility evaluation per ISO 10993-1 with biological risk assessment
- Sterilization validation summary and process documentation
- Software documentation package per IEC 62304 (for devices with software)
- EU Declaration of Conformity (DoC) drafting and review
- FDA 510(k) or PMA submission package (where applicable)
- Post-market surveillance plan and periodic safety update report (PSUR) template
- Design change impact assessment procedures and templates
Applicable Standards & Regulations
EU MDR 2017/745
The European Medical Devices Regulation establishes comprehensive technical documentation requirements in Annex II (technical documentation) and Annex III (post-market surveillance documentation), with General Safety and Performance Requirements defined in Annex I that must be systematically addressed and evidenced.
EU IVDR 2017/746
The In Vitro Diagnostic Medical Devices Regulation imposes parallel technical documentation requirements for IVDs, with specific emphasis on performance evaluation, analytical and clinical performance studies, and the new risk-based classification system replacing the former list-based approach of the IVDD.
ISO 14971:2019
The international standard for the application of risk management to medical devices. ISO 14971 defines the risk management process that produces the risk management file — a critical component of the technical documentation demonstrating systematic hazard identification, risk estimation, risk evaluation, and risk control throughout the device lifecycle.
ISO 13485:2016
The quality management system standard for medical devices provides the procedural framework within which technical documentation is created and maintained. Design and development controls (Clause 7.3), document control (Clause 4.2), and production controls (Clause 7.5) directly govern technical file content and management.
MEDDEV 2.7/1 Rev 4
The European Commission guidance on clinical evaluation under the MDD/MDR, establishing the methodology and content requirements for clinical evaluation reports that form a mandatory component of the technical documentation. Though written under the MDD framework, its principles remain applicable under the MDR and are supplemented by MDCG guidance documents.
FDA 21 CFR Part 807 Subpart E
FDA regulations governing 510(k) premarket notification submissions, defining the content and format requirements for demonstrating substantial equivalence to predicate devices. The submission package includes device description, predicate comparison, performance testing, biocompatibility, software documentation, and labeling.
ISO 10993-1:2018
The framework standard for biological evaluation of medical devices, defining the systematic approach to biocompatibility assessment that must be documented within the technical file. It establishes the process for identifying applicable biological endpoints and selecting appropriate evaluation methods based on device contact type and duration.
IEC 62366-1:2015+A1:2020
The standard for the application of usability engineering to medical devices. Usability engineering documentation — including use specification, user interface evaluation, and summative usability testing results — forms part of the technical file evidence demonstrating GSPR compliance for safe and effective device use.
Frequently Asked Questions
Related Services
Clinical Affairs
Clinical Evaluation Reports, literature reviews, PMCF planning, and data collection
Learn moreRegulatory Strategy & Compliance
Regulatory roadmaps, pathway identification, MDR/IVDR transition, and notified body interaction
Learn morePackaging & Labeling
EU MDR/FDA labeling compliance, ISO 15223-1 symbols, sterile packaging, and multi-language IFU
Learn moreReady to Accelerate Your Regulatory Compliance?
Schedule a free consultation with our senior regulatory experts